ArticleCancers2023

Inhibition of PLK1 Destabilizes EGFR and Sensitizes EGFR-Mutated Lung Cancer Cells to Small Molecule Inhibitor Osimertinib.

Carolien Eggermont et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.